SEC Tracker
Get the app

CalciMedica CALC

CalciMedica (CALC) reports stock option grant.

Alan Glicklich, insider filing for CALC

Form
4
Filed
Importance
Routine
  1. Alan Glicklich, a director, received a stock option on Oct 1, 2026.
  2. The option allows buying 20,000 shares at $1.64.
  3. The option vests over one year, with full vesting by 2027 annual meeting.
  4. The option expires on Sep 30, 2036.

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when CalciMedica files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Pluri PLUR public float $15M, Dec 31, 2025
  2. ProPhase Labs PRPH public float $15M, Jun 30, 2025
  3. Lipocine LPCN public float $16M, Jun 30, 2025
  4. Akari Therapeutics AKTX public float $15M, Jun 30, 2025
  5. X4 Pharmaceuticals XFOR public float $15M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.